Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (I)

Oral Oncology

Volumn 46, Issue 9, 2010, Pages 630-635

  Bello, Ibrahim O ^a   Soini, Ylermi ^b   Salo, Tuula ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Oral (mobile) tongue cancer; Prognosis; Prognostic factors; Review; Squamous cell carcinoma; Survival

Indexed keywords

TUMOR MARKER;

BLOOD ANALYSIS; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER STAGING; HUMAN; NONHUMAN; ORAL TONGUE SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVA ANALYSIS; TONGUE CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956393672     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.06.006     Document Type: Review

References (91)

1. J. Rautava, M. Luukkaa, K. Heikinheimo, J. Alin, R. Grenman, and R.P. Happonen Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival Oral Oncol 43 9 2007 911 919
2. K.M. Sathyan, R. Sailasree, R. Jayasurya, K. Lakshminarayanan, T. Abraham, and K.R. Nalinakumari Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma J Cancer Res Clin Oncol 132 9 2006 601 609
3. K. Rusthoven, A. Ballonoff, D. Raben, and C. Chen Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma Cancer 112 2 2008 345 351
4. J.A. Regezi, J.J. Sciubba, and R.C.K. Jordan Oral pathology: clinical, pathologic correlations 5th ed. 2008 Saunders Elsevier St Louis (MO)
5. M.S. Lim RE: correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et al. J Surg Oncol 93 4 2006 253 254
6. D. Sano, and J.N. Myers Metastasis of squamous cell carcinoma of the oral tongue Cancer Metastasis Rev 26 3-4 2007 645 662
7. Leipzig B, Cummings CW, Chung CT, Johnson JT, Sagerman RH. Carcinoma of the anterior tongue. Ann Otol Rhinol Laryngol 1982;91(1 Pt 1):94-7.
8. R.M. Byers, A.K. El-Naggar, Y.Y. Lee, B. Rao, B. Fornage, and N.H.A. Terry Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 20 2 1998 138 144
9. S.F. Huang, C.J. Kang, C.Y. Lin, K.H. Fan, T.C. Yen, and H.M. Wang Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection Cancer 112 5 2008 1066 1075
10. A.K. D'Cruz, R.C. Siddachari, R.R. Walvekar, G.H. Pantvaidya, D.A. Chaukar, and M.S. Deshpande Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial Head Neck 31 5 2009 618 624
11. K.J. Haddadin, D.S. Soutar, R.J. Oliver, M.H. Webster, A.G. Robertson, and D.G. MacDonald Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection Head Neck 21 6 1999 517 525
12. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
13. E.T. Liu Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology Proc Natl Acad Sci USA 102 10 2005 3531 3532
14. C.W. Elston, J.P. Sloane, I. Amendoeira, N. Apostolikas, J.P. Bellocq, and S. Bianchi Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology Eur J Cancer 36 14 2000 1769 1772
15. S.R. Lakhani, and A. Ashworth Microarray and histopathological analysis of tumours: the future and the past? Nat Rev Cancer 1 2 2001 151 157
16. M.J. Duffy, and J. Crown A personalized approach to cancer treatment: how biomarkers can help Clin Chem 54 11 2008 1770 1779
17. P.J. van Diest, G. Brugal, and J.P. Baak Proliferation markers in tumours: interpretation and clinical value J Clin Pathol 51 10 1998 716 724
18. K.A. Alanen, M. Lintu, and H. Joensuu Image cytometry of breast carcinomas that are DNA diploid by flow cytometry: time to revise the concept of DNA diploidy? Anal Quant Cytol Histol 20 3 1998 178 186
19. B.R. Balsara, A.M. Borges, S.A. Pradhan, R.M. Rajpal, and A.N. Bhisey Flow cytometric DNA analysis of squamous cell carcinomas of the oral cavity: correlation with clinical and histopathological features Eur J Cancer B Oral Oncol 30B 2 1994 98 101
20. J. Hemmer, E. Nagel, and K. Kraft DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavity Anticancer Res 19 2B 1999 1419 1422
21. S. Michiels, S. Koscielny, and C. Hill Prediction of cancer outcome with microarrays: a multiple random validation strategy Lancet 365 9458 2005 488 492
22. E. Nimeus-Malmstrom, C. Ritz, P. Eden, A. Johnsson, M. Ohlsson, and C. Strand Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy Eur J Cancer 42 16 2006 2729 2737
23. D. Dunkler, S. Michiels, and M. Schemper Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis? Eur J Cancer 43 4 2007 745 751
24. X. Fan, L. Shi, H. Fang, Y. Cheng, R. Perkins, and W. Tong DNA microarrays are predictive of cancer prognosis: a re-evaluation Clin Cancer Res 16 2 2010 629 636
25. E. Biganzoli, N. Lama, F. Ambrogi, L. Antolini, and P. Boracchi Prediction of cancer outcome with microarrays Lancet 365 9472 2005 1683
26. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, and M. Mao Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 2002 530 536
27. J.M. Bueno-de-Mesquita, W.H. van Harten, V.P. Retel, L.J. van't Veer, F.S. van Dam, and K. Karsenberg Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) Lancet Oncol 8 12 2007 1079 1087
28. P. Nyberg, T. Salo, and R. Kalluri Tumor microenvironment and angiogenesis Front Biosci 13 2008 6537 6553
29. N.E. Fusenig, D. Breitkreutz, R.T. Dzarlieva, P. Boukamp, A. Bohnert, and W. Tilgen Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo J Invest Dermatol 81 1 Suppl 1983 168s 175s
30. S. Nurmenniemi, T. Sinikumpu, I. Alahuhta, S. Salo, M. Sutinen, and M. Santala A novel organotypic model mimics the tumor microenvironment Am J Pathol 175 3 2009 1281 1291
31. T. Van Dyke, and T. Jacks Cancer modeling in the modern era: progress and challenges Cell 108 2 2002 135 144
32. E. Koivunen, W. Arap, H. Valtanen, A. Rainisalo, O.P. Medina, and P. Heikkila Tumor targeting with a selective gelatinase inhibitor Nat Biotechnol 17 8 1999 768 774
33. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, and G.W. Bell Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 7162 2007 557 563
34. P. Heikkila, J. Suojanen, E. Pirila, A. Vaananen, E. Koivunen, and T. Sorsa Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides Int J Cancer 118 9 2006 2202 2209
35. D.L. McCormick, R.G. Mehta, C.A. Thompson, N. Dinger, J.A. Caldwell, and R.C. Moon Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy Cancer Res 42 2 1982 508 512
36. C.J. Grubbs, P.J. Becci, H.J. Thompson, and R.C. Moon Carcinogenicity of N-methyl-N- nitrosourea and N-ethyl-N-nitrosourea when applied to a localized area of the hamster trachea J Natl Cancer Inst 66 5 1981 961 965
37. J.T. Korpi, V. Kervinen, H. Maklin, A. Vaananen, M. Lahtinen, and E. Laara Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer Brit J Cancer 98 4 2008 766 775
38. M. Vered, S. Polak-Charcon, T. Babushkin, and D. Dayan 4NQO-induced rat tongue carcinoma: an ultrastructural study Ultrastruct Pathol 32 5 2008 199 205
39. J.F. Amatruda, and E.E. Patton Genetic models of cancer in zebrafish Int Rev Cell Mol Biol 271 2008 1 34
40. B. Hu, C. Zhang, K. Baawo, R. Qin, G.J. Cole, and J.A. Lee Zebrafish K5 promoter driven GFP expression as a transgenic system for oral research Oral Oncol 46 1 2010 31 37
41. K. Somasundaram, M.B. Nijaguna, and D.M. Kumar Serum proteomics of glioma: methods and applications Expert Rev Mol Diagn 9 7 2009 695 707
42. J.Y. Wu, C. Yi, H.R. Chung, D.J. Wang, W.C. Chang, and S.Y. Lee Potential biomarkers in saliva for oral squamous cell carcinoma Oral Oncol 46 4 2010 226 231
43. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15(2):594-603.
44. C.M. Sturgeon, L.C. Lai, and M.J. Duffy Serum tumour markers: how to order and interpret them BMJ 339 2009 b3527
45. Y. Yamazaki, I. Chiba, M. Ishikawa, C. Satoh, K. Notani, and Y. Ohiro Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma Odontology 96 1 2008 32 37
46. R.N. Sainger, M.H. Shah, A.A. Desai, S.N. Shukla, P.M. Shah, and S.D. Telang Clinical significance of serum p53 antibodies in oral cancer Tumori 92 2 2006 134 139
47. S.D. Khandavilli, P.O. Ceallaigh, C.J. Lloyd, and R. Whitaker Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma Oral Oncol 45 10 2009 912 914
48. K. Ota, H. Fujimori, M. Ueda, S. Shiniriki, M. Kudo, and H. Jono Midkine as a prognostic biomarker in oral squamous cell carcinoma Brit J Cancer 99 4 2008 655 662
49. M. Krimmel, J. Hoffmann, C. Krimmel, C.P. Cornelius, and N. Schwenzer Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer J Craniomaxillofac Surg 26 4 1998 243 248
50. S. Tamaki, N. Sanefuzi, M. Kawakami, K. Aoki, Y. Imai, and Y. Yamanaka Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients Human Immunol 69 2 2008 88 93
51. Z.J. Shang, J.R. Li, and Z.B. Li Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma J Oral Maxillofac Surg 65 1 2007 17 21
52. L.P. Zhong, H.G. Zhu, C.P. Zhang, W.T. Chen, and Z.Y. Zhang Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma Int J Oral Maxillofac Surg 36 3 2007 230 234
53. R.M. Nagler, M. Barak, M. Peled, H. Ben-Aryeh, M. Filatov, and D. Laufer Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma Cancer 85 5 1999 1018 1025
54. K. Hamana, K. Uzawa, K. Ogawara, M. Shiiba, H. Bukawa, and H. Yokoe Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma Brit J Cancer 92 12 2005 2181 2184
55. G.N. Raval, D.D. Patel, L.J. Parekh, J.B. Patel, M.H. Shah, and P.S. Patel Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer Oral Dis 9 3 2003 119 128
56. J. Hedstrom, R. Grenman, H. Ramsay, P. Finne, J. Lundin, and C. Haglund Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx Int J Cancer 84 5 1999 525 528
57. S.A. Duffy, J.M. Taylor, J.E. Terrell, M. Islam, Y. Li, and K.E. Fowler Interleukin-6 predicts recurrence and survival among head and neck cancer patients Cancer 113 4 2008 750 757
58. P. Pradhan-Palikhe, T. Vesterinen, J. Tarkkanen, I. Leivo, T. Sorsa, and T. Salo Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer Oral Oncol 46 7 2010 514 518
59. R.M. Nagler Saliva as a tool for oral cancer diagnosis and prognosis Oral Oncol 45 12 2009 1006 1010
60. B. Matharoo-Ball, A.K. Miles, C.S. Creaser, G. Ball, and R. Rees Serum biomarker profiling in cancer studies: a question of standardisation? Vet Comp Oncol 6 4 2008 224 247
61. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010;138(3):949-57, e1-7.
62. J.A. Woolgar Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma Oral Oncol 42 3 2006 229 239
63. W. Garavello, R. Spreafico, and R.M. Gaini Oral tongue cancer in young patients: a matched analysis Oral Oncol 43 9 2007 894 897
64. C.T. Liao, H.M. Wang, L.L. Hsieh, J.T. Chang, S.H. Ng, and C. Hsueh Higher distant failure in young age tongue cancer patients Oral Oncol 42 7 2006 718 725
65. D.M. Hyam, R.C. Conway, Y. Sathiyaseelan, V. Gebski, G.J. Morgan, and D.M. Walker Tongue cancer: do patients younger than 40 do worse? Aust Dent J 48 1 2003 50 54
66. Atula S, Grenman R, Laippala P, Syrjanen S. Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg 1996;122(12):1313-9.
67. K. Annertz, H. Anderson, A. Biorklund, T. Moller, S. Kantola, and J. Mork Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults Int J Cancer 101 1 2002 95 99
68. B.J. Davidson, W.A. Root, and B.J. Trock Age and survival from squamous cell carcinoma of the oral tongue Head Neck 23 4 2001 273 279
69. S. Kantola, M. Parikka, K. Jokinen, K. Hyrynkangs, Y. Soini, and O.P. Alho Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors Brit J Cancer 83 5 2000 614 619
70. M.J. Veness, G.J. Morgan, Y. Sathiyaseelan, and V. Gebski Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment Anz J Surg 73 11 2003 899 904
71. N. Siegelmann-Danieli, A. Hanlon, J.A. Ridge, R. Padmore, D.A. Fein, and C.J. Langer Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients J Clin Oncol 16 2 1998 745 753
72. K.T. Pitman, J.T. Johnson, R.L. Wagner, and E.N. Myers Cancer of the tongue in patients less than forty Head Neck 22 3 2000 297 302
73. P.L. Friedlander, S.P. Schantz, A.R. Shaha, G. Yu, and J.P. Shah Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis Head Neck 20 5 1998 363 368
74. A. Popovtzer, T. Shpitzer, G. Bahar, G. Marshak, D. Ulanovski, and R. Feinmesser Squamous cell carcinoma of the oral tongue in young patients Laryngoscope 114 5 2004 915 917
75. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. Eur J Cancer 1998;34(14 Spec No):2154-61.
76. P.W. Dickman, T. Hakulinen, T. Luostarinen, E. Pukkala, R. Sankila, and B. Soderman Survival of cancer patients in Finland 1955-1994 Acta Oncol 38 Suppl 12 1999 1 103
77. Y. Zheng, T. Kirita, N. Kurumatani, M. Sugimura, and K. Yonemasu Trends in oral cancer mortality in Japan: 1950-1993 Oral Dis 5 1 1999 3 9
78. E. Mathew Iype, M. Pandey, A. Mathew, G. Thomas, P. Sebastian, and M. Krishnan Nair Squamous cell carcinoma of the tongue among young Indian adults Neoplasia 3 4 2001 273 277
79. C.H. Shiboski, B.L. Schmidt, and R.C. Jordan Racial disparity in stage at diagnosis and survival among adults with oral cancer in the US Community Dent Oral Epidemiol 35 3 2007 233 240
80. G.J. Macfarlane, L. Sharp, S. Porter, and S. Franceschi Trends in survival from cancers of the oral cavity and pharynx in Scotland: a clue as to why the disease is becoming more common? Brit J Cancer 73 6 1996 805 808
81. W.L. Lo, S.Y. Kao, L.Y. Chi, Y.K. Wong, and R.C. Chang Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival J Oral Maxillofac Surg 61 7 2003 751 758
82. G. El-Husseiny, A. Kandil, A. Jamshed, Y. Khafaga, M. Saleem, and A. Allam Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors Brit J Oral Maxillofac Surg 38 3 2000 193 199
83. K. Yoshida, K. Kashima, S. Suenaga, N. Nomi, J. Shuto, and M. Suzuki Immunohistochemical detection of cervical lymph node micrometastases from T2N0 tongue cancer Acta Otolaryngol 125 6 2005 654 658
84. S. Kaya, T. Yilmaz, B. Gursel, S. Sarac, and L. Sennaroglu The value of elective neck dissection in treatment of cancer of the tongue Am J Otolaryngol 22 1 2001 59 64
85. A. Sparano, G. Weinstein, A. Chalian, M. Yodul, and R. Weber Multivariate predictors of occult neck metastasis in early oral tongue cancer Otolaryngol Head Neck Surg 131 4 2004 472 476
86. M.W.M. van den Brekel, J.A. Castelijns, and G.B. Snow Diagnostic evaluation of the neck Otolaryngol Clin North Am 31 4 1998 601 620
87. H. Keski-Santti, R. Kontio, I. Leivo, J. Tornwall, S. Matzke, and A.A. Makitie Sentinel lymph node biopsy as an alternative to wait and see policy in patients with small T1 oral cavity squamous cell carcinoma Acta Otolaryngol 128 1 2008 98 102
88. R.K. O'Donnell, M. Kupferman, S.J. Wei, S. Singhal, R. Weber, and B. O'Malley Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity Oncogene 24 7 2005 1244 1251
89. P. Roepman, L.F. Wessels, N. Kettelarij, P. Kemmeren, A.J. Miles, and P. Lijnzaad An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas Nat Genet 37 2 2005 182 186
90. S.T. Nguyen, S. Hasegawa, H. Tsuda, H. Tomioka, M. Ushijima, and M. Noda Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma Cancer Sci 98 5 2007 740 746
91. S. Colella, K.L. Richards, L.L. Bachinski, K.A. Baggerly, S. Tsavachidis, and J.C. Lang Molecular signatures of metastasis in head and neck cancer Head Neck 30 10 2008 1273 1283